Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.96 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.60 |
| ▸ | MAOB | P27338 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 6/20 | 0.57 |
| ▸ | CA1 | P00915 | 6/20 | 0.57 |
| ▸ | CA2 | P00918 | 6/20 | 0.57 |
| ▸ | CA9 | Q16790 | 6/20 | 0.57 |
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | STK17B | O94768 | 1/20 | 0.43 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7525285 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL3422180 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL5193445 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL5133849 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL15508929 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL133020 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL7908254 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL2819924 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL22777078 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL598026 | 0.98 | TDP1 (1.00) | TDP1MEN1GAAKMT2AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 916 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613364-A | MrgX2 antagonistic small molecule fluorescent probe, synthesis method thereof and application thereof in MrgX2 detection | 西安交通大学 | 2025-03-14 | — | — | CN | claimed |
| CN-118755307-A | Environment-friendly fluorescent pen ink and preparation method thereof | 慈溪市长城制笔有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-117777187-A | Triphenyl phosphate hapten as well as preparation method and application thereof | 北京维德维康生物技术有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-115353770-B | Gel pen ink with optimized writing performance | 南京一墨纳米技术有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-115353770-A | Gel pen ink with optimized writing performance | 南京一墨纳米技术有限公司 | 2022-11-18 | — | — | CN | claimed |
| CN-114437585-A | Writing pen ink for files and preparation method thereof | 鼎纳科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| EP-3565523-B1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | HERCULES LLC (US) | 2021-09-08 | — | — | EP | claimed |
| CN-112266340-A | Preparation method of 4- (BOC-amino) -1-butanol | 南京麦瑞米生物技术有限公司 | 2021-01-26 | — | — | CN | claimed |
| US-20180193242-A1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | HERCULES LLC (DE) | 2018-07-12 | — | — | US | claimed |
| CN-102249968-B | Synthetic method for sulforaphane | UNIV CHANGZHOU | 2013-07-17 | — | — | CN | claimed |
| US-7223851-B2 | Nucleic acid-binding polymers | GENERAL DYNAMICS ADVANCED INFORMATION SYSTEMS, INC. (US) | 2007-05-29 | — | — | US | claimed |
| US-20040157217-A1 | Nucleic acid-binding polymers | VERIDIAN SYSTEMS DIVISION | 2004-08-12 | — | — | US | claimed |
| EP-1063235-B1 | BENZOFURYLPYRONE DERIVATIVES | TEIJIN LTD (JP) | 2004-05-12 | — | — | EP | claimed |
| US-20030186976-A1 | Benzofurylpyrone derivatives | TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION | 2003-10-02 | — | — | US | claimed |
| US-6589984-B1 | Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as | TEIJIN LIMITED (JP) | 2003-07-08 | — | — | US | claimed |
| EP-1063235-A1 | BENZOFURYLPYRONE DERIVATIVES | TEIJIN LIMITED (JP) | 2000-12-27 | — | — | EP | claimed |
| US-20260138977-A1 | MODULATORS OF BETA CATENIN AND USES THEREOF | DEWPOINT THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4003988-B1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | SERVIER LAB (FR) | 2026-05-20 | — | — | EP | disclosed |
| US-5081246-A | Isoquinolino sulfonamino derivatives | Hidaka, Hiroyoshi (JP) | 1992-01-14 | — | — | US | disclosed |
| US-4479942-A | Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180193242-A1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | FHIT, KAT2B, KAT2A | TDP1 3444/4885MEN1 2848/4885GAA 2752/4885 |
| US-20260138977-A1 | MODULATORS OF BETA CATENIN AND USES THEREOF | CTNNB1, CTNND1, CTNNA1 | TDP1 861/4885MEN1 1798/4885GAA 3342/4885 |
| US-20030186976-A1 | Benzofurylpyrone derivatives | PLIN5, ACSL5, PLIN1 | TDP1 1261/4885MEN1 3634/4885GAA 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.